Cubist Systematic Strategies LLC Purchases New Shares in Viemed Healthcare, Inc. (NASDAQ:VMD)

Cubist Systematic Strategies LLC purchased a new position in Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 55,965 shares of the company's stock, valued at approximately $449,000. Cubist Systematic Strategies LLC owned approximately 0.14% of Viemed Healthcare at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. Barclays PLC lifted its holdings in Viemed Healthcare by 342.3% in the 3rd quarter. Barclays PLC now owns 53,439 shares of the company's stock worth $392,000 after purchasing an additional 41,358 shares in the last quarter. JPMorgan Chase & Co. raised its holdings in shares of Viemed Healthcare by 151.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 98,798 shares of the company's stock worth $724,000 after acquiring an additional 59,538 shares in the last quarter. SG Americas Securities LLC raised its holdings in shares of Viemed Healthcare by 193.1% during the 4th quarter. SG Americas Securities LLC now owns 35,579 shares of the company's stock worth $285,000 after acquiring an additional 23,442 shares in the last quarter. Arrowstreet Capital Limited Partnership purchased a new stake in shares of Viemed Healthcare during the 4th quarter worth approximately $1,549,000. Finally, EntryPoint Capital LLC purchased a new stake in shares of Viemed Healthcare during the 4th quarter worth approximately $92,000. 74.24% of the stock is owned by hedge funds and other institutional investors.

Viemed Healthcare Price Performance

Shares of VMD traded down $0.08 during mid-day trading on Thursday, hitting $6.59. 8,885 shares of the stock were exchanged, compared to its average volume of 140,607. The company has a market cap of $260.46 million, a PE ratio of 24.41 and a beta of 1.49. Viemed Healthcare, Inc. has a 52-week low of $6.14 and a 52-week high of $9.81. The firm has a 50-day moving average of $6.93 and a two-hundred day moving average of $7.80. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.19 and a current ratio of 1.31.

Viemed Healthcare (NASDAQ:VMD - Get Free Report) last issued its quarterly earnings data on Wednesday, May 7th. The company reported $0.06 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.06. The business had revenue of $59.10 million for the quarter, compared to analysts' expectations of $60.60 million. Viemed Healthcare had a return on equity of 8.72% and a net margin of 4.87%.

Viemed Healthcare Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.